Czlonkowska A - Search Results

1

Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.

Sarode GV, Kim K, Kieffer DA, Shibata NM, Litwin T, Czlonkowska A, Medici V. Sarode GV, et al. Among authors: czlonkowska a. Metabolomics. 2019 Mar 12;15(3):43. doi: 10.1007/s11306-019-1505-6. Metabolomics. 2019. PMID: 30868361 Free PMC article.

2

Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.

Seniów J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Seniów J, et al. Among authors: czlonkowska a. Mov Disord. 2002 Sep;17(5):1077-83. doi: 10.1002/mds.10195. Mov Disord. 2002. PMID: 12360563

3

Neurological presentation of Wilson's disease in a patient after liver transplantation.

Litwin T, Gromadzka G, Członkowska A. Litwin T, et al. Among authors: czlonkowska a. Mov Disord. 2008 Apr 15;23(5):743-6. doi: 10.1002/mds.21913. Mov Disord. 2008. PMID: 18181205

4

Late onset Wilson's disease: therapeutic implications.

Członkowska A, Rodo M, Gromadzka G. Członkowska A, et al. Mov Disord. 2008 Apr 30;23(6):896-8. doi: 10.1002/mds.21985. Mov Disord. 2008. PMID: 18311837

5

MR spectroscopy in monitoring the treatment of Wilson's disease patients.

Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A. Tarnacka B, et al. Among authors: czlonkowska a. Mov Disord. 2008 Aug 15;23(11):1560-6. doi: 10.1002/mds.22163. Mov Disord. 2008. PMID: 18546325 Clinical Trial.

6

Monozygotic female twins discordant for phenotype of Wilson's disease.

Członkowska A, Gromadzka G, Chabik G. Członkowska A, et al. Mov Disord. 2009 May 15;24(7):1066-9. doi: 10.1002/mds.22474. Mov Disord. 2009. PMID: 19306278

7

Clinical features of hemolysis, elevated liver enzymes, and low platelet count syndrome in undiagnosed Wilson disease: report of two cases.

Członkowska A, Gromadzka G, Büttner J, Chabik G. Członkowska A, et al. Arch Gynecol Obstet. 2010 Jan;281(1):129-34. doi: 10.1007/s00404-009-1080-6. Epub 2009 Apr 19. Arch Gynecol Obstet. 2010. PMID: 19381668

8

Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain.

Tarnacka B, Szeszkowski W, Buettner J, Gołebiowski M, Gromadzka G, Członkowska A. Tarnacka B, et al. Among authors: czlonkowska a. Metab Brain Dis. 2009 Sep;24(3):463-8. doi: 10.1007/s11011-009-9145-6. Epub 2009 Aug 26. Metab Brain Dis. 2009. PMID: 19707862

9

Concordance rates of Wilson's disease phenotype among siblings.

Chabik G, Litwin T, Członkowska A. Chabik G, et al. Among authors: czlonkowska a. J Inherit Metab Dis. 2014 Jan;37(1):131-5. doi: 10.1007/s10545-013-9625-z. Epub 2013 Jun 18. J Inherit Metab Dis. 2014. PMID: 23774950 Free PMC article.

10

Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.

Gromadzka G, Karpińska A, Przybyłkowski A, Litwin T, Wierzchowska-Ciok A, Dzieżyc K, Chabik G, Członkowska A. Gromadzka G, et al. Among authors: czlonkowska a. Biometals. 2014 Feb;27(1):207-15. doi: 10.1007/s10534-013-9694-3. Epub 2013 Dec 25. Biometals. 2014. PMID: 24368744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters